Trastuzumab Biosimilar Market Size

  • Report ID: 3011
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Trastuzumab Biosimilar Market Size

Trastuzumab Biosimilar Market size is poised to witness lucrative growth rate during the forecast period i.e., between 2024-2036. 

Extensive research associated with cancer treatment in western countries, along with the growing investment in the development of advanced therapies are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing geriatric population and changing lifestyle. According to the data collected from World Health Organization, in 2020, cancer was the leading cause of death worldwide, accounting for nearly 10 million deaths.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3011
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising prevalence of cancer and increasing geriatric population in the world are the key factors driving market growth.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

The side-effects which are associated with the use of trastumuzab biosimilar are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to the increasing population and investments for trastumuzab biosimilar research.

The major players dominating the trastumuzab biosimilar market are Amgen Inc., Biocon Limited, Celltrion Inc., Pfizer Inc., Merck & Co. Inc., Accord Healthcare Ltd. among others.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample